Park Hotels & Resorts Announces Four Hotels Achieved ENERGY STAR® Certification for Superior Energy Performance in 2020
22 avr. 2021 06h00 HE
|
Park Hotels & Resorts Inc.
TYSONS, Va., April 22, 2021 (GLOBE NEWSWIRE) -- Park Hotels & Resorts Inc. (NYSE: PK) (“Park”) today announced that four of its hotels: Hilton Seattle Airport and Conference Center, Hilton Santa...
Vallon Pharmaceuticals Continues Advancement of Pivotal Study in Lead Development Program, ADAIR, Toward Potential Approval
13 avr. 2021 08h05 HE
|
Vallon Pharmaceuticals Inc.
- Ongoing ADAIR SEAL study on target for pivotal data readout in second half of 2021- Target NDA filing in Q2 2022 for a potential abuse-deterrent alternative to commercially available IR amphetamines...
Park Hotels & Resorts Inc. Reports Fourth Quarter and Full Year 2020 Results
25 févr. 2021 16h15 HE
|
Park Hotels & Resorts Inc.
TYSONS, Va., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Park Hotels & Resorts Inc. (“Park” or the “Company”) (NYSE: PK) today announced results for the fourth quarter and full year ended December 31,...
DRGT Completes a Pivotal Phase I Trial; Results Confirm 6X Faster Attainment Of Maximum Plasma Levels For Pain Management Compared To Currently Available COX-2 Inhibitor
10 juin 2019 09h00 HE
|
Druggability Technologies Holdings Ltd
BUDAPEST, Hungary, June 10, 2019 (GLOBE NEWSWIRE) -- Druggability Technologies Holdings (DRGT) today announced results from a pharmacokinetic study of their novel formulation of celecoxib...
CHESAPEAKE LODGING TRUST SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger
06 mai 2019 11h52 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., May 06, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do you own shares of Chesapeake Lodging Trust (NYSE: CHSP)?Did you purchase any of your shares prior to May 6, 2019?Do...
AXIM® Biotech Receives Positive PK Data Results for CanChew Plus® CBD Gum
04 janv. 2017 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, Jan. 04, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, received positive pharmacokinetic (PK)...